A biochemical fluorometric method for assessing the oxidative properties of HDL.
J. Lipid Res., Dec;52(12):2341-51 (2011)
HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer.
Mol. Cancer Ther., Jun;11(6):1311-9 (2012)
Apolipoprotein a-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1Î± in human ovarian cancer cell lines and a mouse ovarian cancer model.
J. Pharmacol. Exp. Ther., Aug;342(2):255-62 (2012)
Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity.
Lipids Health Dis., 11:87 (2012)
L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Integr Biol (Camb)., Apr;3(4):479-89 (2011)
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms.
Nat Rev Cardiol., Apr;8(4):222-32 (2011)
HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL.
Lipids Health Dis., 10:35 (2011)
D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD.
Int. J. Cancer., Mar;130(5):1071-81 (2012)
Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.
J. Lipid Res., Jun;52(6):1200-10 (2011)
Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels.
Mol. Genet. Metab., Sep;101(1):66-75 (2010)
L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.
Drug Metab Lett., Aug;4(3):139-48 (2010)
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.
Proc. Natl. Acad. Sci. U.S.A., Nov;107(46):19997-20002 (2010)
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.
Arthritis Res. Ther., 12(3):R93 (2010)
L-4F Differentially Alters Plasma Levels of Oxidized Fatty Acids Resulting in More Anti-inflammatory HDL in Mice.
Drug Metab Lett., Jun (2010)
Structure and function of HDL mimetics.
Arterioscler. Thromb. Vasc. Biol., Feb;30(2):164-8 (2010)
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
J. Lipid Res., Aug;50(8):1538-47 (2009)
Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein.
J. Biol. Chem., Jul;284(27):18292-301 (2009)
Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis.
Arthritis Rheum., Oct;60(10):2870-9 (2009)
L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation.
Arterioscler. Thromb. Vasc. Biol., Feb;30(2):283-9 (2010)
Peptide Mimetics of Apolipoproteins Improve HDL Function.
J Clin Lipidol., May;1(2):142-7 (2007)